normetanephrine has been researched along with Paraganglioma in 49 studies
Normetanephrine: A methylated metabolite of norepinephrine that is excreted in the urine and found in certain tissues. It is a marker for tumors.
Paraganglioma: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland (usually called a chromaffinoma or pheochromocytoma). It is more common in women than in men. (Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This single-centre, prospective trial investigated the use of CST in 60 patients with suspected PPGL associated with out-patient elevations of plasma normetanephrine (NMN) and/or metanephrine (MN), in most cases accompanied with hypertension or an adrenal mass." | 9.51 | Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use. ( Dralle, H; Führer, D; Geroula, A; Pamporaki, C; Schmid, KW; Tsiomidou, S; Unger, N; Van Baal, L; Weber, F, 2022) |
| "Various studies have validated plasma free metanephrines (MNs) as biomarkers for pheochromocytoma and paraganglioma (PPGL)." | 8.95 | ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS. ( Cao, X; Chen, Y; Huang, X; Li, Y; Xiao, H; Zhou, X, 2017) |
| "Sampling of blood in the supine position for diagnosis of pheochromocytoma and paraganglioma (PPGL) results in lower rates of false positives for plasma normetanephrine than seated sampling." | 8.12 | Preanalytical Considerations and Outpatient Versus Inpatient Tests of Plasma Metanephrines to Diagnose Pheochromocytoma. ( Amar, L; Baron, S; Blanchard, A; Braun, L; Ceccato, F; Davies, E; Deinum, J; Deutschbein, T; Dobrowolski, P; Eisenhofer, G; Fassnacht, M; Gruber, S; Hampson, S; Januszewicz, A; Lenzini, L; Müller, LM; Nölting, S; Pamporaki, C; Pecori, A; Peitzsch, M; Pommer, G; Prejbisz, A; Remde, H; Rossi, GP; Stell, A; Timmers, HJLM; Zennaro, MC, 2022) |
| "Accurate diagnosis of pheochromocytoma and paraganglioma (PPGLs) is highly dependent on the detection of metanephrines and catecholamines." | 8.02 | Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma. ( Cong, H; Gao, X; Guo, Y; Shi, X; Sun, N; Wang, K; Xie, L; Zhang, W; Zhou, Z, 2021) |
| "Measurements of plasma free metanephrines are recommended for diagnosing pheochromocytomas and paragangliomas (PPGL)." | 8.02 | Diagnostic Accuracy of Salivary Metanephrines in Pheochromocytomas and Paragangliomas. ( Eijkelenkamp, K; Kema, IP; Kerstens, MN; Links, TP; Osinga, TE; Pacak, K; Sluiter, WJ; van der Horst-Schrivers, ANA; van Faassen, M, 2021) |
| "The 24 h urinary-fractionated metanephrine (MN) and normetanephrine (NMN) are recommended as the preferred indicators for laboratory diagnosis of pheochromocytoma and paraganglioma (PPGL)." | 7.96 | Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma. ( Cong, H; Dai, S; Gao, X; Shi, X; Wang, K; Zhang, W; Zhou, Z, 2020) |
| "Urinary measurement of fractionated metanephrines is one of the best available biochemical tests for the diagnosis of pheochromocytoma and paraganglioma; however, false-positive results remain an issue." | 7.96 | Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma. ( Bokuda, K; Ichihara, A; Seki, Y; Yatabe, M, 2020) |
| "Plasma free metanephrines are commonly used for diagnosis of pheochromocytoma and paraganglioma (PPGLs), but can also provide other information." | 7.96 | Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma. ( Bechmann, N; Beuschlein, F; Calsina, B; Constantinescu, G; Deutschbein, T; Eisenhofer, G; Fankhauser, M; Fassnacht, M; Fliedner, S; Langton, K; Lenders, JWM; Monteagudo, M; Nölting, S; Pamporaki, C; Peitzsch, M; Prejbisz, A; Robledo, M; Stell, A; Timmers, HJLM, 2020) |
| "In patients with phaeochromocytomas or paragangliomas (PPGLs), 24-h urine collections for metanephrines (uMNs) are cumbersome." | 7.96 | Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas. ( Grossman, AB; Isidori, AM; Jafar-Mohammadi, B; James, T; Maunsell, Z; May, CJH; Sbardella, E; Shine, B; Tadman, M, 2020) |
| "This work discusses the clinical performance of deconjugated metanephrine (MN), normetanephrine (NMN) and 3-methoxytyramine (3MT) determined in the basal first morning urine using a chromatographic method with electrochemical detection for the clinical diagnosis of pheochromocytoma (PHEO) and paraganglioma (PGL)." | 7.81 | Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma. ( Bešťák, J; Bílek, R; Dušková, J; Michalský, D; Novák, K; Vlček, P; Widimský, J; Zelinka, T, 2015) |
| "Measurement of plasma free metanephrines by immunoassay appears to be a useful diagnostic test in patients suspected of pheochromocytoma, with a high specificity as compared with urinary catecholamines." | 7.77 | Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma. ( Christensen, TT; Frystyk, J; Poulsen, PL, 2011) |
| "This single-centre, prospective trial investigated the use of CST in 60 patients with suspected PPGL associated with out-patient elevations of plasma normetanephrine (NMN) and/or metanephrine (MN), in most cases accompanied with hypertension or an adrenal mass." | 5.51 | Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use. ( Dralle, H; Führer, D; Geroula, A; Pamporaki, C; Schmid, KW; Tsiomidou, S; Unger, N; Van Baal, L; Weber, F, 2022) |
| "Plasma-free metanephrines measured by EIA have better diagnostic test characteristics than urinary catecholamines in the diagnosis of pheochromocytoma." | 5.14 | Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors. ( Akker, SA; Burrin, J; Chew, SL; Drake, WM; Finney, H; Grossman, AB; Procopiou, M, 2009) |
| "Various studies have validated plasma free metanephrines (MNs) as biomarkers for pheochromocytoma and paraganglioma (PPGL)." | 4.95 | ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS. ( Cao, X; Chen, Y; Huang, X; Li, Y; Xiao, H; Zhou, X, 2017) |
| "Measurements of plasma metanephrines and methoxytyramine provide a sensitive test for diagnosis of pheochromocytoma/paraganglioma." | 4.84 | False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade. ( Biemann, R; Eisenhofer, G; Pamporaki, C; Peitzsch, M; Rayes, N; Rohm, S; Sabri, O; Sandner, B; Schürfeld, R; Tönjes, A, 2024) |
| "Moderately elevated plasma normetanephrine (NMN) levels are frequent among patients with suspected pheochromocytoma and paraganglioma (PPGL)." | 4.12 | Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine. ( Deutschbein, T; Eisenhofer, G; Fassnacht, M; Fuss, CT; Masjkur, J; Nölting, S; Pamporaki, C; Prejbisz, A; Quinkler, M; Remde, H; Timmers, HJLM, 2022) |
| "Sampling of blood in the supine position for diagnosis of pheochromocytoma and paraganglioma (PPGL) results in lower rates of false positives for plasma normetanephrine than seated sampling." | 4.12 | Preanalytical Considerations and Outpatient Versus Inpatient Tests of Plasma Metanephrines to Diagnose Pheochromocytoma. ( Amar, L; Baron, S; Blanchard, A; Braun, L; Ceccato, F; Davies, E; Deinum, J; Deutschbein, T; Dobrowolski, P; Eisenhofer, G; Fassnacht, M; Gruber, S; Hampson, S; Januszewicz, A; Lenzini, L; Müller, LM; Nölting, S; Pamporaki, C; Pecori, A; Peitzsch, M; Pommer, G; Prejbisz, A; Remde, H; Rossi, GP; Stell, A; Timmers, HJLM; Zennaro, MC, 2022) |
| "Increased plasma normetanephrine levels in patients with CCHD can be explained by the effect of hypoxia." | 4.12 | Comparison of plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease. ( Goricar, K; Janež, A; Jensterle, M; Podbregar, A; Prokšelj, K; Rakusa, M, 2022) |
| "Accurate diagnosis of pheochromocytoma and paraganglioma (PPGLs) is highly dependent on the detection of metanephrines and catecholamines." | 4.02 | Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma. ( Cong, H; Gao, X; Guo, Y; Shi, X; Sun, N; Wang, K; Xie, L; Zhang, W; Zhou, Z, 2021) |
| "Biochemical testing of urinary metanephrines is useful in the diagnosis and monitoring of pheochromocytoma and paragangliomas." | 4.02 | Verifying Clinically Derived Reference Intervals for Daily Excretion Rates of Fractionated Metanephrines Using Modern Indirect Reference Interval Models. ( Doyle, K; Frank, EL, 2021) |
| "Measurements of plasma free metanephrines are recommended for diagnosing pheochromocytomas and paragangliomas (PPGL)." | 4.02 | Diagnostic Accuracy of Salivary Metanephrines in Pheochromocytomas and Paragangliomas. ( Eijkelenkamp, K; Kema, IP; Kerstens, MN; Links, TP; Osinga, TE; Pacak, K; Sluiter, WJ; van der Horst-Schrivers, ANA; van Faassen, M, 2021) |
| "In patients with phaeochromocytomas or paragangliomas (PPGLs), 24-h urine collections for metanephrines (uMNs) are cumbersome." | 3.96 | Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas. ( Grossman, AB; Isidori, AM; Jafar-Mohammadi, B; James, T; Maunsell, Z; May, CJH; Sbardella, E; Shine, B; Tadman, M, 2020) |
| " She had elevated 24-hour urinary normetanephrine and was found to have a paraganglioma arising from the urinary bladder infiltrating the sigmoid colon." | 3.96 | Micturition syncope: a rare presentation of bladder paraganglioma. ( Iyyadurai, R; John, K; Nawahirsha, S; Sunil V, N, 2020) |
| "Plasma free metanephrines are commonly used for diagnosis of pheochromocytoma and paraganglioma (PPGLs), but can also provide other information." | 3.96 | Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma. ( Bechmann, N; Beuschlein, F; Calsina, B; Constantinescu, G; Deutschbein, T; Eisenhofer, G; Fankhauser, M; Fassnacht, M; Fliedner, S; Langton, K; Lenders, JWM; Monteagudo, M; Nölting, S; Pamporaki, C; Peitzsch, M; Prejbisz, A; Robledo, M; Stell, A; Timmers, HJLM, 2020) |
| "Urinary measurement of fractionated metanephrines is one of the best available biochemical tests for the diagnosis of pheochromocytoma and paraganglioma; however, false-positive results remain an issue." | 3.96 | Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma. ( Bokuda, K; Ichihara, A; Seki, Y; Yatabe, M, 2020) |
| "The 24 h urinary-fractionated metanephrine (MN) and normetanephrine (NMN) are recommended as the preferred indicators for laboratory diagnosis of pheochromocytoma and paraganglioma (PPGL)." | 3.96 | Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma. ( Cong, H; Dai, S; Gao, X; Shi, X; Wang, K; Zhang, W; Zhou, Z, 2020) |
| "This work discusses the clinical performance of deconjugated metanephrine (MN), normetanephrine (NMN) and 3-methoxytyramine (3MT) determined in the basal first morning urine using a chromatographic method with electrochemical detection for the clinical diagnosis of pheochromocytoma (PHEO) and paraganglioma (PGL)." | 3.81 | Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma. ( Bešťák, J; Bílek, R; Dušková, J; Michalský, D; Novák, K; Vlček, P; Widimský, J; Zelinka, T, 2015) |
| "Measurement of plasma/urinary catecholamine metabolites--especially normetanephrine (NMN)--represents a gold standard in biochemical detection of succinate dehydrogenase subunit B (SDHB) and D (SDHD)-related pheochromocytomas (PHEO) and paragangliomas (PGL)." | 3.80 | Clinical utility of chromogranin A in SDHx-related paragangliomas. ( Eisenhofer, G; Kantorovich, V; Pacak, K; Prodanov, T; Wesley, R; Zuber, S, 2014) |
| "Measurements of plasma normetanephrine (NMN) and metanephrine (MN) provide a sensitive test for diagnosis of phaeochromocytomas and paragangliomas (PPGLs), but do not allow detection of dopamine-producing tumours." | 3.79 | Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma. ( Arlt, W; Beuschlein, F; Eisenhofer, G; Januszewicz, A; Kroiß, M; Peitzsch, M; Prejbisz, A; Siegert, G, 2013) |
| "Measurement of plasma free metanephrines by immunoassay appears to be a useful diagnostic test in patients suspected of pheochromocytoma, with a high specificity as compared with urinary catecholamines." | 3.77 | Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma. ( Christensen, TT; Frystyk, J; Poulsen, PL, 2011) |
| "Vaginal paraganglioma are rare, atypical, solitary tumors which originate from the female genital tract." | 1.62 | Solitary vaginal paraganglioma with mature sacrococcygeal teratoma: a rare case report. ( Fan, H; Fan, J; Seery, S; Wang, W; Wang, Z; Zhang, Y, 2021) |
| "Hence, paragangliomas are occasionally misdiagnosed, and this results in unanticipated intraoperative hypertensive crisis." | 1.56 | Micturition syncope secondary to urinary bladder paraganglioma. ( Cherian, KE; Johnson, JT; Kapoor, N; Paul, TV, 2020) |
| "The paraganglioma is a rare tumour that can sometimes develop near to the pancreatic gland and can occasionally mimic an intra pancreatic mass." | 1.34 | [Difficult diagnosis of a pancreatic paraganglioma]. ( Crozes, C; Faucompret, S; Milou, F; Pavic, M; Perrot, G; Vincent, E, 2007) |
| "Paragangliomas are rare neuroendocrine tumors and the malignant behaviour, higher than pheochromocytomas, is based on metastases or local recurrence." | 1.30 | [Secreting retroperitoneal paraganglioma. Apropos of a case]. ( Farthouat, P; Meusnier, F; Platel, JP; Pourrière, M; Thouard, H, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.04) | 18.7374 |
| 1990's | 1 (2.04) | 18.2507 |
| 2000's | 4 (8.16) | 29.6817 |
| 2010's | 21 (42.86) | 24.3611 |
| 2020's | 22 (44.90) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, K | 2 |
| Gao, X | 2 |
| Zhang, W | 2 |
| Sun, N | 1 |
| Xie, L | 1 |
| Cong, H | 2 |
| Guo, Y | 1 |
| Shi, X | 2 |
| Zhou, Z | 2 |
| Kamihara, J | 1 |
| Hamilton, KV | 1 |
| Pollard, JA | 1 |
| Clinton, CM | 1 |
| Madden, JA | 1 |
| Lin, J | 1 |
| Imamovic, A | 1 |
| Wall, CB | 1 |
| Wassner, AJ | 1 |
| Weil, BR | 1 |
| Heeney, MM | 1 |
| Vargas, SO | 1 |
| Kaelin, WG | 1 |
| Janeway, KA | 1 |
| Perini, RF | 1 |
| Zojwalla, NJ | 1 |
| Voss, SD | 1 |
| DuBois, SG | 1 |
| Richter, S | 2 |
| Qiu, B | 1 |
| Ghering, M | 1 |
| Kunath, C | 1 |
| Constantinescu, G | 2 |
| Luths, C | 1 |
| Pamporaki, C | 7 |
| Bechmann, N | 2 |
| Meuter, L | 1 |
| Kwapiszewska, A | 1 |
| Deutschbein, T | 5 |
| Nölting, S | 4 |
| Peitzsch, M | 8 |
| Robledo, M | 3 |
| Prejbisz, A | 7 |
| Pacak, K | 7 |
| Gudziol, V | 1 |
| Timmers, HJLM | 4 |
| Eisenhofer, G | 13 |
| Tsiomidou, S | 1 |
| Geroula, A | 1 |
| Van Baal, L | 1 |
| Weber, F | 1 |
| Dralle, H | 1 |
| Schmid, KW | 1 |
| Führer, D | 1 |
| Unger, N | 1 |
| Remde, H | 2 |
| Quinkler, M | 1 |
| Masjkur, J | 1 |
| Fuss, CT | 1 |
| Fassnacht, M | 4 |
| Pommer, G | 1 |
| Müller, LM | 1 |
| Braun, L | 1 |
| Gruber, S | 1 |
| Pecori, A | 1 |
| Hampson, S | 1 |
| Davies, E | 1 |
| Stell, A | 3 |
| Rossi, GP | 1 |
| Lenzini, L | 1 |
| Ceccato, F | 1 |
| Deinum, J | 1 |
| Amar, L | 1 |
| Blanchard, A | 1 |
| Baron, S | 1 |
| Dobrowolski, P | 1 |
| Januszewicz, A | 4 |
| Zennaro, MC | 1 |
| Jensterle, M | 1 |
| Podbregar, A | 1 |
| Janež, A | 1 |
| Rakusa, M | 1 |
| Goricar, K | 1 |
| Prokšelj, K | 1 |
| Zeng, HL | 1 |
| Wang, X | 1 |
| Li, HJ | 1 |
| Yang, Q | 1 |
| Tan, JL | 1 |
| Toh, PY | 1 |
| Ling, S | 1 |
| De Filpo, G | 1 |
| Parenti, G | 1 |
| Sparano, C | 1 |
| Rastrelli, G | 1 |
| Rapizzi, E | 1 |
| Martinelli, S | 1 |
| Amore, F | 1 |
| Badii, B | 1 |
| Paolo, P | 1 |
| Ercolino, T | 1 |
| Mannelli, M | 3 |
| Maggi, M | 1 |
| Canu, L | 1 |
| Schürfeld, R | 1 |
| Rayes, N | 1 |
| Sabri, O | 1 |
| Rohm, S | 1 |
| Biemann, R | 1 |
| Sandner, B | 1 |
| Tönjes, A | 1 |
| Takekoshi, K | 1 |
| Satoh, F | 1 |
| Tanabe, A | 1 |
| Okamoto, T | 1 |
| Ichihara, A | 2 |
| Tsuiki, M | 1 |
| Katabami, T | 1 |
| Nomura, M | 1 |
| Tanaka, T | 1 |
| Matsuda, T | 1 |
| Imai, T | 1 |
| Yamada, M | 1 |
| Asada, S | 1 |
| Kawata, N | 1 |
| Naruse, M | 1 |
| Bokuda, K | 1 |
| Yatabe, M | 1 |
| Seki, Y | 1 |
| Johnson, JT | 1 |
| Cherian, KE | 1 |
| Kapoor, N | 1 |
| Paul, TV | 1 |
| Dai, S | 1 |
| Sbardella, E | 1 |
| Maunsell, Z | 1 |
| May, CJH | 1 |
| Tadman, M | 1 |
| James, T | 1 |
| Jafar-Mohammadi, B | 1 |
| Isidori, AM | 1 |
| Grossman, AB | 3 |
| Shine, B | 1 |
| Fowler, D | 1 |
| Irving, H | 1 |
| Borzi, P | 1 |
| Trnka, P | 1 |
| Huynh, T | 1 |
| Sunil V, N | 1 |
| John, K | 1 |
| Nawahirsha, S | 1 |
| Iyyadurai, R | 1 |
| Langton, K | 1 |
| Calsina, B | 1 |
| Monteagudo, M | 1 |
| Fliedner, S | 2 |
| Fankhauser, M | 1 |
| Beuschlein, F | 3 |
| Lenders, JWM | 1 |
| Jian, M | 1 |
| Huang, H | 1 |
| Li, K | 1 |
| Chuan, L | 1 |
| Li, L | 1 |
| Jiang, L | 1 |
| Doyle, K | 1 |
| Frank, EL | 1 |
| Eijkelenkamp, K | 1 |
| Osinga, TE | 2 |
| van Faassen, M | 1 |
| Kema, IP | 2 |
| Kerstens, MN | 1 |
| Sluiter, WJ | 1 |
| Links, TP | 1 |
| van der Horst-Schrivers, ANA | 1 |
| Wang, Z | 1 |
| Fan, H | 1 |
| Fan, J | 1 |
| Seery, S | 1 |
| Wang, W | 1 |
| Zhang, Y | 1 |
| Chen, Y | 1 |
| Xiao, H | 2 |
| Zhou, X | 1 |
| Huang, X | 1 |
| Li, Y | 1 |
| Cao, X | 1 |
| Hulkower, R | 1 |
| Gubbi, S | 1 |
| Meholli, M | 1 |
| Schubart, U | 1 |
| Gieldon, L | 1 |
| Masjkur, JR | 1 |
| Därr, R | 1 |
| Lahera, M | 1 |
| Aust, D | 1 |
| Zeugner, S | 1 |
| Rump, A | 1 |
| Hackmann, K | 1 |
| Tzschach, A | 1 |
| Schrock, E | 1 |
| Klink, B | 1 |
| Yan, Q | 1 |
| Bancos, I | 1 |
| Gruber, LM | 1 |
| Bancos, C | 1 |
| McKenzie, TJ | 1 |
| Babovic-Vuksanovic, D | 1 |
| Young, WF | 1 |
| Wcislak, SM | 1 |
| King, WS | 1 |
| Waller, BR | 1 |
| Goins, N | 1 |
| Dickson, PV | 1 |
| Mangelis, A | 1 |
| Huebner, A | 1 |
| Boyd, J | 1 |
| Leung, AA | 1 |
| Sadrzadeh, HS | 1 |
| Kline, GA | 1 |
| Kroiß, M | 1 |
| Arlt, W | 1 |
| Siegert, G | 3 |
| Brown, S | 1 |
| Pelzel, D | 1 |
| Lattke, P | 1 |
| Glöckner, S | 1 |
| Reichmann, H | 1 |
| van Berkel, A | 1 |
| Lenders, JW | 2 |
| Timmers, HJ | 2 |
| Zuber, S | 1 |
| Wesley, R | 1 |
| Prodanov, T | 1 |
| Kantorovich, V | 1 |
| Oleaga-Alday, A | 1 |
| Goñi-Goicoechea, F | 1 |
| Calles-Romero, L | 1 |
| Pérez de Ciriza-Cordeu, M | 1 |
| Paja-Fano, M | 1 |
| Teixeira, J | 1 |
| Almeida, M | 1 |
| Afonso, M | 1 |
| Pinto, A | 1 |
| Bílek, R | 1 |
| Zelinka, T | 1 |
| Vlček, P | 1 |
| Dušková, J | 1 |
| Michalský, D | 1 |
| Novák, K | 1 |
| Bešťák, J | 1 |
| Widimský, J | 1 |
| Procopiou, M | 1 |
| Finney, H | 1 |
| Akker, SA | 1 |
| Chew, SL | 1 |
| Drake, WM | 1 |
| Burrin, J | 1 |
| Vesin, C | 1 |
| Cadi, P | 1 |
| Thony, F | 1 |
| Picard, JC | 1 |
| Descotes, JL | 1 |
| Calizzano, A | 1 |
| Baguet, JP | 1 |
| Swaminathan, K | 1 |
| Duvall, E | 1 |
| Akyol, M | 1 |
| Van Der Horst-Schrivers, AN | 1 |
| Van Der Laan, BF | 1 |
| Dullaart, RP | 1 |
| Christensen, TT | 1 |
| Frystyk, J | 1 |
| Poulsen, PL | 1 |
| Bornstein, SR | 2 |
| Friberg, P | 1 |
| Milosevic, D | 1 |
| Linehan, WM | 1 |
| Adams, K | 1 |
| KANDRAC, M | 1 |
| JIRGL, V | 1 |
| Ahlman, H | 1 |
| Gimenez-Roqueplo, AP | 1 |
| Kimura, N | 1 |
| McNicol, AM | 1 |
| Tischler, AS | 1 |
| Perrot, G | 1 |
| Pavic, M | 1 |
| Milou, F | 1 |
| Crozes, C | 1 |
| Faucompret, S | 1 |
| Vincent, E | 1 |
| Farthouat, P | 1 |
| Platel, JP | 1 |
| Meusnier, F | 1 |
| Pourrière, M | 1 |
| Thouard, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pheochromocytoma Randomised Study Comparing Adrenoreceptor Inhibiting Agents for Preoperative Treatment[NCT01379898] | Phase 4 | 134 participants (Actual) | Interventional | 2011-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for normetanephrine and Paraganglioma
| Article | Year |
|---|---|
ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Topics: Adrenal Gland Neoplasms; Biomarkers; Chromatography, Liquid; Humans; Immunoenzyme Techniques; Metane | 2017 |
Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Biomarkers, Tumor; Catecholamines; Dopamine; False Negative Reaction | 2014 |
Laboratory evaluation of pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Clinical Laboratory Techniques; Dopamine; Humans; Metanephrine; Normetaneph | 2014 |
3 trials available for normetanephrine and Paraganglioma
| Article | Year |
|---|---|
Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
Topics: Adrenal Gland Neoplasms; Clonidine; Humans; Hypertension; Metanephrine; Normetanephrine; Paraganglio | 2022 |
Correlation between urinary fractionated metanephrines in 24-hour and spot urine samples for evaluating the therapeutic effect of metyrosine: a subanalysis of a multicenter, open-label phase I/II study.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Child; Fe | 2019 |
Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Catecholamines; Child; Cohort S | 2009 |
43 other studies available for normetanephrine and Paraganglioma
| Article | Year |
|---|---|
Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Anticoagulants; Catecholamines; Dopamine; Epinephrine; Hemoglobins; Humans; | 2021 |
Belzutifan, a Potent HIF2α Inhibitor, in the Pacak-Zhuang Syndrome.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Basic Helix-Loop-Helix Transcription Factors; B | 2021 |
Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine.
Topics: Catecholamines; Dopamine; Female; Head and Neck Neoplasms; Humans; Male; Mutation; Normetanephrine; | 2022 |
Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine.
Topics: Adrenal Gland Neoplasms; Clonidine; Humans; Metanephrine; Normetanephrine; Paraganglioma; Pheochromo | 2022 |
Preanalytical Considerations and Outpatient Versus Inpatient Tests of Plasma Metanephrines to Diagnose Pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Humans; Inpatients; Metanephrine; Normetanephrine; Outpatients; Paraganglio | 2022 |
Comparison of plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease.
Topics: Adrenal Gland Neoplasms; Adult; Cross-Sectional Studies; Female; Heart Defects, Congenital; Humans; | 2022 |
Quantitative analysis of catecholamines and their metabolites in 491 patients with adrenal tumors: a retrospective single-center cohort study.
Topics: Adrenal Gland Neoplasms; Cohort Studies; Humans; Metanephrine; Normetanephrine; Paraganglioma; Pheoc | 2023 |
Unusual presentation of a rare catecholamine-secreting sinonasal paraganglioma.
Topics: Catecholamines; Humans; Male; Normetanephrine; Paraganglioma; Tomography, X-Ray Computed | 2023 |
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study.
Topics: Adrenal Gland Neoplasms; Catecholamines; Doxazosin; Female; Hemodynamics; Humans; Male; Middle Aged; | 2023 |
False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade.
Topics: Adrenal Gland Neoplasms; Antidepressive Agents, Tricyclic; Humans; Metanephrine; Norepinephrine; Nor | 2024 |
Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Age Factors; Aged; Aged, 80 and over; Female; Humans; Male; Metaneph | 2020 |
Micturition syncope secondary to urinary bladder paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenergic alpha-1 Receptor Antagonists; Adult; Diagnosis, Differential; Diag | 2020 |
Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Chromatography, Liquid; Dopamine; Female; Humans; Male; Metanephrine; Norme | 2020 |
Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Age Factors; Aged; Aged, 80 and over; Area Under Curve; | 2020 |
A Rare and Unusual Cause of Unilateral Ureteric Obstruction in a Child.
Topics: Child; Female; Humans; Norepinephrine; Normetanephrine; Paraganglioma; Ureteral Neoplasms; Ureteral | 2020 |
Micturition syncope: a rare presentation of bladder paraganglioma.
Topics: Aged; Cystectomy; Female; Humans; Normetanephrine; Paraganglioma; Syncope; Treatment Outcome; Ultras | 2020 |
Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Algorithms; Biomarkers, Tumor; Dopamine; Fe | 2020 |
A 3-min UPLC-MS/MS method for the simultaneous determination of plasma catecholamines and their metabolites: Method verification and diagnostic efficiency.
Topics: Adrenal Gland Neoplasms; Calibration; Catecholamines; Chromatography, Liquid; Dopamine; Female; Huma | 2021 |
Verifying Clinically Derived Reference Intervals for Daily Excretion Rates of Fractionated Metanephrines Using Modern Indirect Reference Interval Models.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Child; Female; Humans; Likeliho | 2021 |
Diagnostic Accuracy of Salivary Metanephrines in Pheochromocytomas and Paragangliomas.
Topics: Adrenal Gland Neoplasms; Adult; Chromatography, Liquid; Humans; Male; Metanephrine; Normetanephrine; | 2021 |
Solitary vaginal paraganglioma with mature sacrococcygeal teratoma: a rare case report.
Topics: Adult; Female; Humans; Magnetic Resonance Imaging; Norepinephrine; Normetanephrine; Paraganglioma; S | 2021 |
Hypertensive emergency masquerading as phaeochromocytoma: a report of two cases.
Topics: Adrenal Gland Neoplasms; Aged; Diagnosis, Differential; False Positive Reactions; Humans; Hypertensi | 2017 |
Next-generation panel sequencing identifies
Topics: Adrenal Gland Neoplasms; Adult; Base Sequence; Carcinoma, Neuroendocrine; Codon, Nonsense; Epinephri | 2018 |
When Biochemical Phenotype Predicts Genotype: Pheochromocytoma and Paraganglioma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Female; Genotype; Germ-Line Mutatio | 2018 |
Multifocal pheochromocytoma-paraganglioma in a 29-year-old woman with cyanotic congenital heart disease.
Topics: Adrenal Gland Neoplasms; Adult; Female; Heart Defects, Congenital; Humans; Norepinephrine; Normetane | 2019 |
Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy.
Topics: Adolescent; Adrenal Gland Neoplasms; Aging; Blood Chemical Analysis; Catecholamines; Child; Child, P | 2019 |
A high rate of modestly elevated plasma normetanephrine in a population referred for suspected PPGL when measured in a seated position.
Topics: Adrenal Gland Neoplasms; Adult; Canada; Female; Humans; Male; Middle Aged; Normetanephrine; Paragang | 2019 |
Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Blood Chemical Analysis; Chromatography, High Pressure Liquid; | 2013 |
Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
Topics: Aged; Aged, 80 and over; Chromatography, Liquid; Dopamine; Epinephrine; Female; Humans; Levodopa; Ma | 2014 |
Clinical utility of chromogranin A in SDHx-related paragangliomas.
Topics: Adult; Aged; Biomarkers; Child; Child, Preschool; Chromogranin A; Head and Neck Neoplasms; Humans; M | 2014 |
Paraganglioma and cyanotic congenital heart disease: The role of tisular hipoxia.
Topics: Adult; Biomarkers, Tumor; Cyanosis; Disease Susceptibility; Eisenmenger Complex; Female; Gene Expres | 2015 |
Much more than anxiety...
Topics: 3-Iodobenzylguanidine; Abdomen; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Anxiety; Chromo | 2015 |
Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Biomarkers; Chromatography, High Pressure Liquid; Clinical Lab | 2015 |
A rare cause of complicated hypertension: urinary bladder paraganglioma.
Topics: Adult; Humans; Hypertension; Magnetic Resonance Imaging; Male; Normetanephrine; Paraganglioma; Posit | 2009 |
When numbers do not add up!
Topics: Diagnosis, Differential; Humans; Kidney Neoplasms; Male; Metanephrine; Middle Aged; Normetanephrine; | 2011 |
Dopamine excess in patients with head and neck paragangliomas.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Dopamine; Epinephrine; Female; Head and Neck Neoplas | 2010 |
Phaeochromocytoma: a catecholamine and oxidative stress disorder.
Topics: Adenosine Triphosphate; Adrenal Gland Neoplasms; Catecholamines; Humans; Metanephrine; Multiple Endo | 2011 |
Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aged, 80 and over; Catecholamines; | 2011 |
Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.
Topics: Adrenal Gland Neoplasms; Adult; Biomarkers, Tumor; Dopamine; Female; Humans; Male; Middle Aged; Muta | 2012 |
[METANEPHRINE, NORMETANEPHRINE AND METABOLITES OF CATECHOLAMINES].
Topics: Catecholamines; Chromatography; Electrophoresis; Epinephrine; Humans; Metanephrine; Normetanephrine; | 1963 |
Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Biomarkers, Tumor; Child; Humans; Metanephrine; Middle A | 2007 |
[Difficult diagnosis of a pancreatic paraganglioma].
Topics: Adult; Biomarkers, Tumor; Chromogranin A; Diagnosis, Differential; Female; Follow-Up Studies; Humans | 2007 |
[Secreting retroperitoneal paraganglioma. Apropos of a case].
Topics: Chemotherapy, Adjuvant; Dehydroepiandrosterone; Female; Humans; Metanephrine; Middle Aged; Normetane | 1997 |